A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation.
Hamaguchi T, Kato K, Yasui H, Morizane C, Ikeda M, Ueno H, Muro K, Yamada Y, Okusaka T, Shirao K, Shimada Y, Nakahama H, Matsumura Y.
Hamaguchi T, et al. Among authors: matsumura y.
Br J Cancer. 2007 Jul 16;97(2):170-6. doi: 10.1038/sj.bjc.6603855. Epub 2007 Jun 26.
Br J Cancer. 2007.
PMID: 17595665
Free PMC article.